An Oral Small Molecule VEGFR2 Inhibitor, Apatinib, in Patients with Recurrent or Refractory Cervical Cancer: A Real World Study

To evaluate the efficacy and safety of apatinib, an oral antiangiogenic drug, in patients with recurrent or refractory cervical cancer as salvage treatment, we retrospectively analyzed the medical records of recurrent or refractory cervical cancer patients admitted to the National Cancer Center/Canc...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Oncol
Главные авторы: Li, Ning, Wang, Ziyi, Yuan, Guangwen, Sun, Yangchun, Zhang, Rong, Li, Xiaoguang, Li, Nan, Wang, Jing, Wu, Lingying
Формат: Artigo
Язык:Inglês
Опубликовано: Hindawi 2020
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7327550/
https://ncbi.nlm.nih.gov/pubmed/32655637
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/3852373
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы